330350 — Withus Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Withus Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	42,478	26,556	11,192	18,893	19,440
Net Total Accounts Receivable
Net Total Receivables	24,228	23,372	30,978	26,099	29,206
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	76,427	59,451	58,247	61,173	67,740
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,379	39,843	49,945	49,236	47,531
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	118,979	119,395	130,780	134,687	136,645
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,975	25,572	31,011	33,938	32,859
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	38,074	36,359	40,502	41,571	38,638
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Other Equity
Total Equity	80,905	83,036	90,278	93,117	98,007
Total Liabilities & Shareholders' Equity	118,979	119,395	130,780	134,687	136,645
Total Common Shares Outstanding